CDK2 and breast carcinoma: Consistent with the biochemical results, our immunohistochemical analysis of breast cancer tissue microarrays showed significant positive correlation of RHBDD1, p-Akt and CDK2 protein levels, indicating that these proteins have clinicopathological relevance.